Kirtan kriya meditation
Kirtan kriya meditation has been studied in 2 papers since 2016: 2 trials in people. The newest paper, Jan 1, 2018: “Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial”.
2 papers study it6 findingsUpdated
See all 2 papers on kirtan kriya meditation
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Relative to ML, those assigned to KK showed greater gains in perceived stress, mood, psychological well-being, and QOL-Mental Health (p's≤0.09).”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute of General Medical Sciences and 2 more
- Human trial2
Studies in people
2 studies gave kirtan kriya meditation to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves cognitive function | Randomized trial12 weeks | 53 peopleadults with subjective cognitive declinePatient cohorts | Journal of Alzheimer's disease : JAD, Jan 1, 2018 |
down: Decreases perceived stress up: Improves mood up: Improves mental health-related quality of life | Randomized trial12 weeks | 60 peopleolder adultsOlder adults; subjective cognitive decline | Journal of Alzheimer's disease : JAD, Apr 8, 2016 |
What did studies of kirtan kriya meditation find?
6Studies of kirtan kriya meditation measured 6 outcomes, among them cognitive function, amyloid-beta 40 and sleep quality.
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Kirtan kriya meditation improves cognitive function in humans.
“Both groups improved in cognitive and psychosocial status (ps ≤0.05), with improvements in stress, mood, and QOL greater in the KK group.”
Human trial12 minutes/day12 weeksn = 53
Journal of Alzheimer's disease : JAD
Amyloid-beta 40
upin humans1
1 study
Amyloid-beta 40
upin humans1
Kirtan kriya meditation increases amyloid-beta 40 in humans (compared with music listening).
“The KK group showed significantly greater increases in Aβ40 than the ML group.”
Human trialcompared with music listeningplasma12 minutes/day12 weeksn = 53
Journal of Alzheimer's disease : JAD
Sleep quality
upin humans1
1 study
Sleep quality
upin humans1
Kirtan kriya meditation improves sleep quality in humans (subjective cognitive decline; change from baseline).
“Participants in both groups showed significant improvement at 12 weeks in psychological well-being and in multiple domains of mood and sleep quality (p's≤0.05).”
Human trialsubjective cognitive decline; change from baseline12 minutes daily12 weeks
Journal of Alzheimer's disease : JAD
Mental health-related quality of life
upin humans1
1 study
Mental health-related quality of life
upin humans1
Kirtan kriya meditation improves mental health-related quality of life in humans (subjective cognitive decline; compared with music listening).
“Relative to ML, those assigned to KK showed greater gains in perceived stress, mood, psychological well-being, and QOL-Mental Health (p's≤0.09).”
Human trialsubjective cognitive decline; compared with music listening12 minutes daily12 weeks
Journal of Alzheimer's disease : JAD
Mood
upin humans1
1 study
Mood
upin humans1
Kirtan kriya meditation improves mood in humans (subjective cognitive decline; compared with music listening).
“Relative to ML, those assigned to KK showed greater gains in perceived stress, mood, psychological well-being, and QOL-Mental Health (p's≤0.09).”
Human trialsubjective cognitive decline; compared with music listening12 minutes daily12 weeks
Journal of Alzheimer's disease : JAD
Perceived stress
downin humans1
1 study
Perceived stress
downin humans1
Kirtan kriya meditation decreases perceived stress in humans (subjective cognitive decline; compared with music listening).
“Relative to ML, those assigned to KK showed greater gains in perceived stress, mood, psychological well-being, and QOL-Mental Health (p's≤0.09).”
Human trialsubjective cognitive decline; compared with music listening12 minutes daily12 weeks
Journal of Alzheimer's disease : JAD